Share Your Feedback

Pathos

AI

Biotechnology

11-50 employees

AI-enabled drug development built for patients

Founded in 2020

Chicago, Illinois, USA

11-50 employees

https://pathos.com

Funding

Late Stage

Current Stage

$365M

Recent Funding

$447M

Total Funding

Leadership Team

Andrea Mazzocchi, PhD

Vice President, Partnerships

Recent News

AI, genomics expert leaves Pathos AI, will advise Pfizer

pharmaphorum

Alphamab Licenses Cancer Drug to Pathos AI in Deal Worth More Than US$2.2 Billion

EqualOcean

Pathos AI Closes $2.3B Cancer Drug Deals to Prove AI Can Design Smarter Trials

Tech Times